Mild Cognitive Impairment
International Perspectives
📘 About This Book
Mild Cognitive Impairment (MCI) has been identified as an important clinical transition between normal aging and the early stages of Alzheimer's disease (AD). Since treatments for AD are most likely to be most effective early in the course of the disease, MCI has become a topic of great importance and has been investigated in different populations of interest in many countries. This book brings together these differing perspectives on MCI for the first time. This volume provides a comprehensive resource for clinicians, researchers, and students involved in the study, diagnosis, treatment, and rehabilitation of people with MCI. Clinical investigators initially defined mild cognitive impairment (MCI) as a transitional condition between normal aging and the early stages of Alzheimer’s disease (AD). Because the prevalence of AD increases with age and very large numbers of older adults are affected worldwide, these clinicians saw a pressing need to identify AD as early as possible. It is at this very early stage in the disease course that treatments to slow the progress and control symptoms are likely to be most effective. Since the first introduction of MCI, research interest has grown exponentially, and the utility of the concept has been investigated from a variety of perspectives in different populations of interest (e.g., clinical samples, volunteers, population-based screening) in many different countries. Much variability in findings has resulted. Although it has been acknowledged that the differences observed between samples may be ‘legitimate variations’, there has been no attempt to understand what it is we have learned about MCI (i.e., common features and differences) from each of these perspectives. This book brings together information about MCI in different populations from around the world. Mild Cognitive Impairment will be an important resource for any clinician, researcher, or student involved in the study, detection, treatment, and rehabilitation of people with MCI.
📖 Summary
Mild Cognitive Impairment, edited by Holly A. Tuokko and published in 2013 across 317 pages, addresses one of the most critical and heavily investigated subjects in modern psychology, neurology, and gerontology. The book explores Mild Cognitive Impairment, widely recognized as a significant clinical transition phase bridging normal aging processes and the early onset of Alzheimer's disease. As medical science increasingly points toward early intervention as the key to maximizing the effectiveness of potential Alzheimer's treatments, understanding this transitional state has become paramount for professionals across the globe. This volume successfully bridges diverse international perspectives, bringing together various global viewpoints and research findings on MCI for the very first time in a single comprehensive resource. The text serves as an indispensable guide for clinicians, researchers, and students who are actively involved in the complex processes of studying, diagnosing, treating, and rehabilitating individuals experiencing MCI. Clinical investigators originally established the framework for mild cognitive impairment to categorize patients who exhibit cognitive deficits greater than what would be expected for their age and education level, yet do not meet the full diagnostic criteria for dementia or Alzheimer's disease. Tuokko's volume dives deep into the nuances of this definition, examining how different populations manifest these symptoms and how researchers across various countries approach the condition. Throughout the pages of this book, readers are presented with a multifaceted exploration of the diagnostic challenges and clinical realities surrounding MCI. Because the condition represents a crucial window of opportunity, the book emphasizes the importance of accurate identification and early management. By synthesizing international research, the publication highlights both the commonalities and the cultural or demographic differences in how cognitive decline is observed and treated worldwide. This makes the book not only a scientific repository of current knowledge but also a practical tool for improving patient outcomes through informed rehabilitation and clinical care strategies. Ultimately, the work stands as a cornerstone reference for anyone dedicated to navigating the complex landscape of cognitive aging and neurodegenerative disease progression.
🎯 Key Lessons
⚖️ Pros & Cons
✅ Pros
Brings together diverse international perspectives on MCI for the first time
Serves as a comprehensive resource for multiple professional disciplines
Focuses heavily on the crucial early window for Alzheimer's intervention
Provides valuable insights for both clinical diagnosis and patient rehabilitation
⚠️ Cons
May be too heavily focused on clinical and academic perspectives for general readers
Published in 2013, so some rapidly evolving recent neurological breakthroughs may not be included
❓ FAQ
Who is the author of Mild Cognitive Impairment? +
The book was edited by Holly A. Tuokko.
When was the book published? +
It was published in 2013.
How many pages does the book contain? +
The volume contains 317 pages.
What is the core subject of the book? +
The book focuses on Mild Cognitive Impairment as a transition between normal aging and Alzheimer's disease.
Who is the intended audience for this book? +
It is designed for clinicians, researchers, and students involved in cognitive health and rehabilitation.
